Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Pulse Biosciences Q4 EPS $(0.22) Up From $(0.25) YoY

Author: Benzinga Newsdesk | March 28, 2024 04:29pm
Pulse Biosciences (NASDAQ:PLSE) reported quarterly losses of $(0.22) per share. This is a 12 percent increase over losses of $(0.25) per share from the same period last year.

Posted In: PLSE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist